Literature DB >> 3264507

Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases.

B Lenarcic1, D Gabrijelcic, B Rozman, M Drobnic-Kosorok, V Turk.   

Abstract

Synovial fluid of patients with different inflammatory and metabolic joint diseases contains low-molecular CPIs (stefins and cystatins) and high-molecular CPIs (kininogens). An additional inhibitory fragment with a molecular mass of about 20 kDa, which is a part of the kininogen molecule, has been detected. Cathepsin B and cystatin C were determined by ELISA test in 47 patients with rheumatoid arthritis, seronegative spondylarthritis, osteoarthritis, undifferentiated arthritis and gout. A significantly higher amount of cathepsin B was found in patients with rheumatoid arthritis. The elevation of cathepsin B was accompanied by an increased amount of cystatin C.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264507

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  11 in total

1.  Schistosoma japonicum cystatin attenuates murine collagen-induced arthritis.

Authors:  Fang Liu; Weisheng Cheng; Faustina Pappoe; Xiaodong Hu; Huiqin Wen; Qingli Luo; Shushu Wang; Fang Deng; Yuanyuan Xie; Yuanhong Xu; Jilong Shen
Journal:  Parasitol Res       Date:  2016-07-08       Impact factor: 2.289

2.  The genes of the lysosomal cysteine proteinases cathepsin B, H, L, and S map to different mouse chromosomes.

Authors:  J Deussing; W Roth; W Rommerskirch; B Wiederanders; K von Figura; C Peters
Journal:  Mamm Genome       Date:  1997-04       Impact factor: 2.957

3.  Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera.

Authors:  N Després; G Talbot; B Plouffe; G Boire; H A Ménard
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis.

Authors:  J P Morko; M Söderström; A-M K Säämänen; H J Salminen; E I Vuorio
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

5.  A double-headed cathepsin B inhibitor devoid of warhead.

Authors:  Patricia Schenker; Pietro Alfarano; Peter Kolb; Amedeo Caflisch; Antonio Baici
Journal:  Protein Sci       Date:  2008-09-16       Impact factor: 6.725

6.  Cathepsin B in osteoarthritis: zonal variation of enzyme activity in human femoral head cartilage.

Authors:  A Baici; D Hörler; A Lang; C Merlin; R Kissling
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

7.  Cystatin C influences the autoimmune but not inflammatory response to cartilage type II collagen leading to chronic arthritis development.

Authors:  Alexandra Bäcklund; Meirav Holmdahl; Ragnar Mattsson; Katarina Håkansson; Veronica Lindström; Kutty Selva Nandakumar; Anders Grubb; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2011-03-28       Impact factor: 5.156

8.  High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis.

Authors:  Reuben Gobezie; Alvin Kho; Bryan Krastins; David A Sarracino; Thomas S Thornhill; Michael Chase; Peter J Millett; David M Lee
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  A Microbial Feed Additive Abates Intestinal Inflammation in Atlantic Salmon.

Authors:  Ghana Vasanth; Viswanath Kiron; Amod Kulkarni; Dalia Dahle; Jep Lokesh; Yoichiro Kitani
Journal:  Front Immunol       Date:  2015-08-19       Impact factor: 7.561

10.  Suppression of Human T Cell Proliferation Mediated by the Cathepsin B Inhibitor, z-FA-FMK Is Due to Oxidative Stress.

Authors:  Tanuja Rajah; Sek Chuen Chow
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.